quadranoside IV

Details

Top
Internal ID c68cf2ca-e647-4105-a209-dc8225685593
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate
SMILES (Canonical) CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O
SMILES (Isomeric) C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H]([C@@]5(C)CO)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O
InChI InChI=1S/C36H58O10/c1-18-9-12-36(31(44)46-30-28(42)27(41)26(40)22(16-37)45-30)14-13-34(5)20(25(36)19(18)2)7-8-24-32(3)15-21(39)29(43)33(4,17-38)23(32)10-11-35(24,34)6/h7,18-19,21-30,37-43H,8-17H2,1-6H3/t18-,19+,21-,22-,23-,24-,25+,26-,27+,28-,29+,30+,32+,33+,34-,35-,36+/m1/s1
InChI Key OEGYWKLSOORPGU-SXLQXSQGSA-N
Popularity 4 references in papers

Physical and Chemical Properties

Top
Molecular Formula C36H58O10
Molecular Weight 650.80 g/mol
Exact Mass 650.40299804 g/mol
Topological Polar Surface Area (TPSA) 177.00 Ų
XlogP 3.90
Atomic LogP (AlogP) 2.29
H-Bond Acceptor 10
H-Bond Donor 7
Rotatable Bonds 4

Synonyms

Top
CHEBI:67952
2alpha,3beta,23alpha-trihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranoside
CHEMBL500352
Q27136430
1-O-[2alpha,3beta,23-trihydroxy-28-oxours-12-en-28-yl]-beta-D-glucopyranose
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate

2D Structure

Top
2D Structure of quadranoside IV

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7816 78.16%
Caco-2 - 0.8376 83.76%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.7714 77.14%
Subcellular localzation Mitochondria 0.8204 82.04%
OATP2B1 inhibitior - 0.5819 58.19%
OATP1B1 inhibitior + 0.8717 87.17%
OATP1B3 inhibitior - 0.3793 37.93%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.6776 67.76%
BSEP inhibitior - 0.5171 51.71%
P-glycoprotein inhibitior + 0.6718 67.18%
P-glycoprotein substrate - 0.6702 67.02%
CYP3A4 substrate + 0.7087 70.87%
CYP2C9 substrate - 0.8050 80.50%
CYP2D6 substrate - 0.8436 84.36%
CYP3A4 inhibition - 0.8962 89.62%
CYP2C9 inhibition - 0.9176 91.76%
CYP2C19 inhibition - 0.8899 88.99%
CYP2D6 inhibition - 0.9428 94.28%
CYP1A2 inhibition - 0.8393 83.93%
CYP2C8 inhibition + 0.6614 66.14%
CYP inhibitory promiscuity - 0.9592 95.92%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6960 69.60%
Eye corrosion - 0.9909 99.09%
Eye irritation - 0.9243 92.43%
Skin irritation - 0.5684 56.84%
Skin corrosion - 0.9512 95.12%
Ames mutagenesis - 0.8600 86.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7411 74.11%
Micronuclear - 0.8500 85.00%
Hepatotoxicity - 0.7750 77.50%
skin sensitisation - 0.9134 91.34%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity + 0.9222 92.22%
Mitochondrial toxicity + 0.5125 51.25%
Nephrotoxicity - 0.6326 63.26%
Acute Oral Toxicity (c) III 0.7112 71.12%
Estrogen receptor binding + 0.6175 61.75%
Androgen receptor binding + 0.7584 75.84%
Thyroid receptor binding - 0.5738 57.38%
Glucocorticoid receptor binding + 0.6763 67.63%
Aromatase binding + 0.6273 62.73%
PPAR gamma + 0.6281 62.81%
Honey bee toxicity - 0.7437 74.37%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.6350 63.50%
Fish aquatic toxicity + 0.9323 93.23%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.55% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.08% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.09% 97.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.51% 95.56%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 86.53% 94.45%
CHEMBL1994 P08235 Mineralocorticoid receptor 86.38% 100.00%
CHEMBL253 P34972 Cannabinoid CB2 receptor 85.14% 97.25%
CHEMBL2581 P07339 Cathepsin D 84.42% 98.95%
CHEMBL3714130 P46095 G-protein coupled receptor 6 84.41% 97.36%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 83.14% 95.50%
CHEMBL1293249 Q13887 Kruppel-like factor 5 81.91% 86.33%
CHEMBL5255 O00206 Toll-like receptor 4 81.56% 92.50%
CHEMBL5608 Q16288 NT-3 growth factor receptor 80.89% 95.89%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 80.34% 94.33%

Cross-Links

Top
PubChem 10372074
NPASS NPC108709
LOTUS LTS0176769
wikiData Q27136430